2005
DOI: 10.1136/bjo.2004.063933
|View full text |Cite
|
Sign up to set email alerts
|

Novel rhodopsin mutations and genotype-phenotype correlation in patients with autosomal dominant retinitis pigmentosa

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
13
0

Year Published

2006
2006
2020
2020

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 19 publications
(13 citation statements)
references
References 37 publications
0
13
0
Order By: Relevance
“…Mutations that affect RHO transport tend to manifest as more severe degenerations than D190N, which prolongs RHO signaling 11, 12. It has also been suggested that cytoplasmic and extracellular mutations in RHO such as D190N have less severe pheontypes than transmembrane mutations 36.…”
Section: Discussionmentioning
confidence: 99%
“…Mutations that affect RHO transport tend to manifest as more severe degenerations than D190N, which prolongs RHO signaling 11, 12. It has also been suggested that cytoplasmic and extracellular mutations in RHO such as D190N have less severe pheontypes than transmembrane mutations 36.…”
Section: Discussionmentioning
confidence: 99%
“…Another 12 genes are also known to cause adRP. Among these, mutations in the RP1 (retinitis pigmentosa 1), RDS ⁄ peripherin (retinal degeneration slow ⁄ peripherin) and IMPDH1 (inosine monophosphate dehydrogenase 1) genes are the most frequently occurring (Schuster et al 2005).…”
Section: Introductionmentioning
confidence: 99%
“…These findings support previous research in suggesting that extracellular mutations cause milder phenotypes in RHO-associated RP. [23][24][25] The differences in disease expression between affected domains can be attributed to the biochemical defects caused by the mutations within these domains, although external modifiers such as increased light exposure, especially in the development of sector RP, may also play a role. 2,7 A limitation of this study is its retrospective nature, which limited a complete ascertainment of clinical data.…”
Section: Discussionmentioning
confidence: 99%